CHE - Chemed Corp Stock Price, Fair Value and News

572.07USD-8.29 (-1.43%)Delayed as of 08 May 2024, 03:00 pm ET

Market Summary

USD572.07-8.29

Delayedas of 08 May 2024, 03:00 pm

-1.43%

CHE Alerts

1 major insider sales recently.

CHE Stock Price

View Fullscreen

CHE RSI Chart

CHE Valuation

Market Cap

8.8B

Price/Earnings (Trailing)

30.96

Price/Sales (Trailing)

3.83

EV/EBITDA

19.91

Price/Free Cashflow

29.02

CHE Price/Sales (Trailing)

CHE Profitability

Operating Margin

56.30%

EBT Margin

15.86%

Return on Equity

23.95%

Return on Assets

16.4%

Free Cashflow Yield

3.45%

CHE Fundamentals

CHE Revenue

Revenue (TTM)

2.3B

Rev. Growth (Yr)

5.19%

Rev. Growth (Qtr)

0.57%

CHE Earnings

Earnings (TTM)

283.4M

Earnings Growth (Yr)

20.13%

Earnings Growth (Qtr)

-27.8%

Breaking Down CHE Revenue

52 Week Range

492.84580.30

(Low)(High)

Last 7 days

2.1%

Last 30 days

-8.0%

Last 90 days

-2.2%

Trailing 12 Months

5.0%

How does CHE drawdown profile look like?

CHE Financial Health

Current Ratio

1.91

Debt/Equity

0.01

Debt/Cashflow

21.81

CHE Investor Care

Dividend Yield

0.27%

Dividend/Share (TTM)

1.58

Shares Dilution (1Y)

1.04%

Diluted EPS (TTM)

18.59

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	2.3B	0	0	0
2023	2.2B	2.2B	2.2B	2.3B
2022	2.1B	2.1B	2.1B	2.1B
2021	2.1B	2.1B	2.1B	2.1B
2020	2.0B	2.0B	2.1B	2.1B
2019	1.8B	1.9B	1.9B	1.9B
2018	1.7B	1.7B	1.8B	1.8B
2017	1.6B	1.6B	1.6B	1.7B
2016	1.6B	1.6B	1.6B	1.6B
2015	1.5B	1.5B	1.5B	1.5B
2014	1.4B	1.4B	1.4B	1.5B
2013	1.4B	1.4B	1.4B	1.4B
2012	1.4B	1.4B	1.4B	1.4B
2011	1.3B	1.3B	1.3B	1.4B
2010	1.2B	1.2B	1.2B	1.3B
2009	0	1.2B	1.2B	1.2B
2008	0	0	0	1.1B

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Chemed Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 30, 2024	lee spencer s	gifted	-	-	-1,133	executive vice president
Mar 28, 2024	lee spencer s	sold (taxes)	-4,557,960	643	-7,080	executive vice president
Mar 28, 2024	lee spencer s	sold	-1,283,300	641	-2,000	executive vice president
Mar 28, 2024	lee spencer s	acquired	1,385,670	106	13,000	executive vice president
Mar 21, 2024	witzeman michael d	sold	-1,704,320	643	-2,650	vp & chief financial officer
Mar 20, 2024	judkins brian c	acquired	5,300,010	443	11,958	vp and chief legal officer
Mar 20, 2024	judkins brian c	sold	-7,196,910	645	-11,158	vp and chief legal officer
Mar 20, 2024	witzeman michael d	sold (taxes)	-229,841	647	-355	vp & chief financial officer
Mar 20, 2024	witzeman michael d	acquired	1,074,290	413	2,600	vp & chief financial officer

Which funds bought or sold CHE recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 06, 2024	HighTower Advisors, LLC	reduced	-0.95	99,000	1,408,000	-%
May 06, 2024	Envestnet Portfolio Solutions, Inc.	reduced	-0.45	72,578	859,925	-%
May 06, 2024	Schechter Investment Advisors, LLC	new	-	700,987	700,987	0.05%
May 06, 2024	AIA Group Ltd	sold off	-100	-524,521	-	-%
May 06, 2024	ORG Partners LLC	reduced	-96.34	-184,122	7,686	0.01%
May 06, 2024	NewEdge Wealth, LLC	added	11.43	193,233	3,098,240	0.07%
May 06, 2024	NEW YORK LIFE INVESTMENT MANAGEMENT LLC	reduced	-2.1	72,680	1,045,700	0.01%
May 06, 2024	Advisory Services Network, LLC	unchanged	-	57,558	650,268	0.01%
May 06, 2024	LSV ASSET MANAGEMENT	sold off	-100	-982,000	-	-%
May 06, 2024	TEXAS PERMANENT SCHOOL FUND CORP	added	1.31	853,154	8,461,920	0.07%

Are Funds Buying or Selling CHE?

Are funds buying CHE calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own CHE

No. of Funds

CHE Alerts

1 major insider sales recently.

Unveiling Chemed Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	11.28%	1,699,648	SC 13G/A
Jan 24, 2024	blackrock inc.	9.4%	1,409,958	SC 13G/A
Feb 09, 2023	vanguard group inc	11.38%	1,692,377	SC 13G/A
Jan 24, 2023	blackrock inc.	9.4%	1,399,535	SC 13G
Feb 09, 2022	vanguard group inc	11.31%	1,740,446	SC 13G/A
Feb 01, 2022	blackrock inc.	8.7%	1,343,981	SC 13G/A
Feb 10, 2021	vanguard group inc	11.41%	1,819,635	SC 13G/A
Jan 29, 2021	blackrock inc.	9.2%	1,463,600	SC 13G/A
Feb 12, 2020	vanguard group inc	12.04%	1,928,122	SC 13G/A
Feb 05, 2020	blackrock inc.	9.9%	1,578,926	SC 13G/A

Recent SEC filings of Chemed Corp

View All Filings

Date Filed	Form Type	Document
May 01, 2024	4	Insider Trading
Apr 29, 2024	10-Q	Quarterly Report
Apr 24, 2024	8-K	Current Report
Apr 17, 2024	8-K	Current Report
Apr 08, 2024	DEF 14A	DEF 14A
Apr 01, 2024	4	Insider Trading
Mar 22, 2024	4	Insider Trading
Mar 22, 2024	4	Insider Trading
Mar 20, 2024	144	Notice of Insider Sale Intent
Mar 13, 2024	8-K	Current Report

Peers (Alternatives to Chemed Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	462.0B	371.6B	9.96%	1.73%	20.64	1.24	14.64%	11.24%
CI	98.5B	206.0B	-4.33%	31.01%	25.56	0.48	12.55%	-43.95%
HCA	82.4B	66.7B	-4.37%	13.20%	15.06	1.23	9.59%	-4.59%
CVS	70.0B	360.9B	-25.27%	-20.02%	9.55	0.19	9.07%	78.49%
CNC	40.5B	155.5B	4.29%	11.16%	14.81	0.26	6.34%	84.42%
DVA	12.1B	12.3B	3.05%	54.33%	14.8	0.98	5.77%	58.74%
UHS	11.7B	14.3B	-2.27%	18.37%	16.37	0.82	6.59%	6.24%
MID-CAP
CHE	8.8B	2.3B	-7.98%	4.98%	30.96	3.83	5.96%	18.29%
ACHC	6.3B	3.0B	-11.24%	-2.13%	-553.66	2.09	10.92%	-104.06%
AMN	2.3B	3.8B	3.83%	-33.34%	10.82	0.6	-27.73%	-52.50%
AMEH	2.1B	1.4B	-9.08%	8.52%	34.65	1.52	21.19%	34.42%
SMALL-CAP
ADUS	1.7B	1.1B	2.42%	25.02%	26.07	1.57	11.45%	30.74%
BKD	1.4B	3.0B	8.71%	84.46%	-7.37	0.46	6.74%	20.73%
BEAT	54.0M	-	-2.35%	-2.35%	-3.69	-	-	-12.94%
AMS	19.6M	21.3M	10.24%	15.77%	36.7	0.92	8.00%	-62.25%

Chemed Corp News

Latest updates

Chemed Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	0.6%	589	586	565	554	560	547	526	531	531	541	539	532	527	528	528	502	516	522	481	474	462
Costs and Expenses	8.9%	517	475	478	484	487	465	446	439	441	443	446	461	447	390	454	409	436	445	416	408	413
S&GA Expenses	15.4%	116	100	100	95.00	100	97.00	84.00	88.00	90.00	92.00	89.00	94.00	92.00	87.00	88.00	85.00	71.00	83.00	77.00	72.00	74.00
EBITDA Margin	1.9%	0.19*	0.18*	0.17*	0.17*	0.17*	0.18*	0.19*	0.20*	0.19*	0.19*	0.22*	0.21*	0.22*	0.22*	0.19*	0.18*	0.17*	0.16*	0.15*	-	-
Interest Expenses	24.3%	0.00	0.00	0.00	1.00	2.00	2.00	1.00	1.00	1.00	1.00	1.00	0.00	0.00	0.00	0.00	1.00	1.00	1.00	1.00	1.00	1.00
Income Taxes	-23.8%	19.00	26.00	18.00	17.00	17.00	20.00	20.00	20.00	21.00	22.00	23.00	19.00	18.00	32.00	14.00	18.00	13.00	14.00	8.00	14.00	6.00
Earnings Before Taxes	-26.9%	84.00	116	93.00	70.00	71.00	82.00	76.00	86.00	85.00	96.00	95.00	75.00	84.00	146	82.00	100	69.00	80.00	67.00	64.00	51.00
EBT Margin	2.5%	0.16*	0.15*	0.14*	0.14*	0.15*	0.15*	0.16*	0.17*	0.16*	0.16*	0.19*	0.18*	0.20*	0.19*	0.16*	0.16*	0.14*	0.13*	0.13*	-	-
Net Income	-27.8%	65.00	90.00	75.00	53.00	54.00	62.00	57.00	66.00	64.00	75.00	72.00	57.00	65.00	114	68.00	82.00	56.00	66.00	59.00	51.00	45.00
Net Income Margin	2.7%	0.12*	0.12*	0.11*	0.10*	0.11*	0.12*	0.12*	0.13*	0.12*	0.13*	0.14*	0.14*	0.16*	0.15*	0.13*	0.13*	0.12*	0.11*	0.11*	-	-
Free Cashflow	-25.2%	72.00	97.00	17.00	116	43.00	82.00	39.00	44.00	88.00	49.00	102	9.00	89.00	71.00	114	176	69.00	50.00	117	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	3.6%	1,728	1,668	1,562	1,505	1,431	1,442	1,356	1,313	1,306	1,343	1,318	1,384	1,458	1,435	1,367	1,291	1,278	1,268	1,233	1,094	1,070
Current Assets	7.7%	540	501	395	337	262	273	199	203	185	230	201	269	347	329	271	189	199	191	168	180	159
Cash Equivalents	18.7%	313	264	173	160	58.00	74.00	8.00	10.00	18.00	33.00	29.00	92.00	210	163	113	20.00	29.00	6.00	9.00	3.00	9.00
Inventory	-10.8%	11.00	12.00	13.00	12.00	11.00	10.00	10.00	11.00	11.00	10.00	8.00	7.00	7.00	7.00	8.00	7.00	7.00	7.00	7.00	6.00	6.00
Net PPE	-0.5%	203	204	205	208	204	200	194	192	192	194	191	193	190	188	181	183	184	176	173	150	165
Goodwill	1.1%	592	585	585	582	581	581	580	580	580	579	579	579	579	579	579	578	577	577	577	511	511
Liabilities	-2.9%	544	560	543	553	551	643	635	628	639	719	538	513	529	534	566	540	594	542	560	476	482
Current Liabilities	-9.6%	282	312	297	302	283	297	298	285	280	302	286	267	290	299	329	319	247	262	252	224	217
Long Term Debt	-	-	-	-	-	16.00	93.00	96.00	112	120	185	-	-	-	-	-	-	160	90.00	130	85.00	100
LT Debt, Current	-	-	-	-	-	5.00	5.00	5.00	5.00	-	-	-	-	-	-	-	-	-	-	-	-	-
LT Debt, Non Current	-	-	-	-	-	16.00	93.00	96.00	112	120	185	-	-	-	-	-	-	160	90.00	130	85.00	100
Shareholder's Equity	6.8%	1,183	1,108	1,019	952	880	799	721	685	667	623	780	871	929	901	801	751	684	727	672	619	588
Retained Earnings	2.4%	2,506	2,447	2,363	2,294	2,246	2,198	2,141	2,090	2,029	1,970	1,901	1,835	1,784	1,724	1,615	1,553	1,476	1,426	1,365	1,311	1,265
Additional Paid-In Capital	4.3%	1,399	1,341	1,254	1,240	1,186	1,150	1,100	1,089	1,064	1,044	1,008	1,000	983	961	925	904	879	861	842	817	804
Accumulated Depreciation	2.9%	365	355	348	342	338	336	338	330	326	318	311	307	299	293	289	281	279	270	264	259	254
Shares Outstanding	0.5%	15.00	15.00	15.00	15.00	15.00	15.00	15.00	15.00	15.00	16.00	16.00	16.00	16.00	16.00	16.00	16.00	16.00	16.00	16.00	-	-
Float	-	-	-	-	8,050	-	-	-	6,872	-	-	-	7,332	-	-	-	7,056	-	-	-	5,635	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-22.1%	84,549	108,563	28,927	132,317	60,492	100,199	52,017	56,580	101,090	63,570	112,988	25,320	106,719	86,877	124,590	188,496	89,326	63,604	128,738	35,322	73,585
Cashflow From Investing	-66.1%	-19,385	-11,670	-15,438	-16,521	-17,013	-19,488	-14,279	-11,687	-13,948	-14,045	-10,410	-15,879	-17,423	-15,962	-10,220	-13,885	-21,493	-13,098	-149,213	-14,515	-13,934
Cashflow From Financing	-159.2%	-15,772	-6,085	-263	-13,926	-59,551	-14,366	-39,597	-53,413	-101,877	-45,373	-165,955	-127,477	-41,815	-21,005	-21,981	-183,186	-45,040	-53,414	26,218	-26,252	-55,714
Dividend Payments	-0.1%	6,050	6,056	6,034	5,727	5,685	5,626	5,669	5,400	5,322	5,559	5,593	5,427	5,437	5,440	5,401	5,108	5,130	5,131	5,090	4,768	4,799
Buy Backs	-3.7%	38,460	39,928	14,344	-	-	12,976	24,325	49,420	27,794	245,662	163,731	125,542	41,107	28,471	24,975	21,913	100,235	20,705	-	22,676	49,250

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

CHE Income Statement

2024-03-31

Consolidated Statements Of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Consolidated Statements Of Income [Abstract]
Service revenues and sales	$ 589,233	$ 560,157
Cost of services provided and goods sold (excluding depreciation)	385,127	370,705
Selling, general and administrative expenses	115,873	100,095
Depreciation	13,287	12,286
Amortization	2,521	2,513
Other operating expense	92	1,739
Total costs and expenses	516,900	487,338
Income from operations	72,333	72,819
Interest expense	(425)	(1,551)
Other income/(expense) - net	12,577	(103)
Income before income taxes	84,485	71,165
Income taxes	(19,468)	(17,044)
Net income	$ 65,017	$ 54,121
Earnings Per Share:
Net income	$ 4.30	$ 3.62
Average number of shares outstanding	15,121	14,966
Diluted Earnings Per Share:
Net income	$ 4.24	$ 3.58
Average number of shares outstanding	15,339	15,110
Cash Dividends Per Share	$ 0.40	$ 0.38

CHE Balance Sheet

2024-03-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 313,350	$ 263,958
Accounts receivable less allowances	177,334	181,511
Inventories	10,712	12,004
Prepaid income taxes	9,790	13,166
Prepaid expenses	28,431	30,204
Total current assets	539,617	500,843
Investments of deferred compensation plans held in trust	117,649	106,126
Properties and equipment, at cost, less accumulated depreciation of $365,074 (2023- $354,872)	202,784	203,840
Lease right of use asset	131,751	126,387
Identifiable intangible assets less accumulated amortization of $51,485 (2023 - $48,965)	88,137	90,264
Goodwill	591,519	585,017
Other assets	56,176	55,618
Total Assets	1,727,633	1,668,095
Current liabilities
Accounts payable	56,203	64,034
Income taxes	27,353	6,858
Accrued insurance	62,055	58,568
Accrued compensation	49,802	88,381
Accrued legal	7,183	6,386
Short-term lease liability	39,279	38,635
Other current liabilities	40,099	49,188
Total current liabilities	281,974	312,050
Deferred income taxes	24,899	30,321
Deferred compensation liabilities	117,550	104,069
Long-term lease liability	106,861	100,776
Other liabilities	12,854	13,003
Total Liabilities	544,138	560,219
Commitments and contingencies (Note 10)
STOCKHOLDERS' EQUITY
Capital stock - authorized 80,000,000 shares $1 par; issued 37,297,015 shares (2023 - 37,183,681 shares)	37,297	37,184
Paid-in capital	1,398,733	1,341,273
Retained earnings	2,505,892	2,446,925
Treasury stock - 22,212,667 shares (2023 - 22,148,927 shares)	(2,760,543)	(2,719,588)
Deferred compensation payable in Company stock	2,116	2,082
Total Stockholders' Equity	1,183,495	1,107,876
Total Liabilities and Stockholders' Equity	$ 1,727,633	$ 1,668,095

About Chemed Corp

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

CEO	Mr. Kevin J. McNamara
WEBSITE	chemed.com
INDUSTRY	Healthcare Plans
EMPLOYEES	14167

Chemed Corp Frequently Asked Questions

What is the ticker symbol for Chemed Corp? What does CHE stand for in stocks?

CHE is the stock ticker symbol of Chemed Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Chemed Corp (CHE)?

As of Tue May 07 2024, market cap of Chemed Corp is 8.78 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CHE stock?

You can check CHE's fair value in chart for subscribers.

What is the fair value of CHE stock?

You can check CHE's fair value in chart for subscribers. The fair value of Chemed Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Chemed Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CHE so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Chemed Corp a good stock to buy?

The fair value guage provides a quick view whether CHE is over valued or under valued. Whether Chemed Corp is cheap or expensive depends on the assumptions which impact Chemed Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CHE.

What is Chemed Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue May 07 2024, CHE's PE ratio (Price to Earnings) is 30.96 and Price to Sales (PS) ratio is 3.83. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CHE PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Chemed Corp's stock?

In the past 10 years, Chemed Corp has provided 0.216 (multiply by 100 for percentage) rate of return.